logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
PLRZ
Polyrizon Ltd.
10.99
1 x 9.90
1 x 11.49
bid
ask
-
0.34
3.00%
12:34 PM
timesize
Ytd29.45%
1y77.83%
9.99
day range
11.30
2.88
52 week range
18.20
Open11.30Prev Close11.33Low9.99High11.30Mkt Cap12.31M
Vol24.99KAvg Vol45.80KEPS-1.96P/E-5.61Forward P/EN/A
Beta-1.50Short Ratio0.08Inst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg12.86200-d Avg11.921yr Est0.00

PLRZ News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session.

Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial
globenewswire.com
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement

Raanana, Israel, July 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
globenewswire.com
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Tria

Raanana, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “

Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform
globenewswire.com
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform

Raanana, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
globenewswire.com
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time an

New performance and characterization study in collaboration with leading European medical center mar

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology
globenewswire.com
Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Deli

Raanana, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “

Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial
globenewswire.com
Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial

Raanana, Israel, June 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial
globenewswire.com
Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Alle

Raanana, Israel, May 13, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “P

Pulse Equity: Emerging Outbreaks - Polyrizon's Approach to Broad and Rapidly Deployable Protection
prnewswire.com
Pulse Equity: Emerging Outbreaks - Polyrizon's Approach to Broad and Rapidly Deployable Protection

In light of the growing challenges posed by emerging respiratory threats, including recent Hantaviru

Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
globenewswire.com
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform

Raanana, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “P

Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform
globenewswire.com
Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platfor

Raanana, Israel, April 27, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or

Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
globenewswire.com
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements

RAANANA, ISRAEL, April 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a

Polyrizon Provides 2025 and Recent Highlights
globenewswire.com
Polyrizon Provides 2025 and Recent Highlights

Company Concluded 2025 with Robust Cash Position, Debt-Free Balance Sheet and Significant Pipeline A

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
globenewswire.com
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

Raanana, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or th

Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defense and Urban Air Mobility Applications
globenewswire.com
Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defen

The Company signed a non-binding MOU with shareholders of Colugo. Colugo's customer include the Isra

Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program
globenewswire.com
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Pro

Raanana, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or th

Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study
globenewswire.com
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAqui

Raanana, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or th

Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product
globenewswire.com
Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposi

Raanana, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the

Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker
prnewswire.com
Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker

HONG KONG, Feb. 17, 2026 /PRNewswire/ -- Early in 2026, Polyrizon Ltd. (Nasdaq: PLRZ), a pre-clinica

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator
globenewswire.com
Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator

The Company signed a non-binding MOU agreement with Arrow Aviation, a lucrative high- growth company

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
globenewswire.com
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen For

Collaboration aims to leverage Polyrizon's advanced proprietary intranasal delivery platform to supp

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Why Confluent Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Confluent Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Ulta Beauty Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Ulta Beauty Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

US Stocks Edge Higher; Dollar General Shares Jump After Upbeat Earnings
benzinga.com
US Stocks Edge Higher; Dollar General Shares Jump After Upbeat Earnings

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why American Eagle Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why American Eagle Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Gold Down Over 1%; Signet Shares Fall After Q3 Results
benzinga.com
Gold Down Over 1%; Signet Shares Fall After Q3 Results

Nasdaq Surges 200 Points; United Natural Foods Posts Upbeat Earnings
benzinga.com
Nasdaq Surges 200 Points; United Natural Foods Posts Upbeat Earnings
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Pre
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session